TrialCritical care (London, England)2024

Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial.

Rombout B E van Amstel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.